Peter R. Dottino, MD, has been appointed Director of the Division of Gynecologic Oncology in the Department of Obstetrics, Gynecology and Reproductive Medicine at the Mount Sinai Health System in New York. He also holds an appointment as Associate Clinical Professor at the Icahn School of Medicine at Mount Sinai.
Dr. Dottino is Director of the Group for Women and Co-Director with John A. Martignetti, MD, of the Ovarian Cancer Translational Research Laboratory at Mount Sinai. He previously served as the Director of Gynecologic Oncology at Mount Sinai and also is one of the founders of the Ovarian Cancer Research Fund, a United States charity funding ovarian cancer research.
Rudy Albert Segna, MD, named Associate Director of Gynecologic Oncology, and Ann Marie Beddoe, MD, named Director of the Gynecologic Oncology Chemotherapy Infusion Service join Dr. Dottino at Mount Sinai as faculty members.
Dr. Dottino received his medical degree at Georgetown Medical School in Washington, DC, and completed his chief residency at Downstate Medical Center/Kings County Hospital, and a fellowship in gynecologic oncology at The Mount Sinai Hospital.
Dr. Segna was awarded his medical degree at New York University School of Medicine, and completed a chief residency at the Naval Medical Center in San Diego, and a fellowship at Mount Sinai. He also served as the Director of Gynecologic Oncology and the Colposcopy Service at the Naval Medical Center in Portsmouth, Virginia.
Dr. Beddoe has been Assistant Professor in Gynecologic Oncology at Mount Sinai, and previously served as the Director of the Gynecologic Oncology Services at City Hospital in Elmhurst, New York. She was awarded her medical degree from the State University of New York Downstate Medical School, where she also completed residency training and a fellowship. Dr. Beddoe completed a fellowship in clinical nutrition at Memorial Sloan Kettering Cancer Center in New York. ■